Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis

about

Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis

Item

http://www.wikidata.org/entity/Q57108835

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Aldehyde dehydrogenase 1 as a ...... breast cancer: A meta-analysis

@en

Aldehyde dehydrogenase 1 as a ...... breast cancer: A meta-analysis

@nl

type

Item

label

Aldehyde dehydrogenase 1 as a ...... breast cancer: A meta-analysis

@en

Aldehyde dehydrogenase 1 as a ...... breast cancer: A meta-analysis

@nl

prefLabel

Aldehyde dehydrogenase 1 as a ...... breast cancer: A meta-analysis

@en

Aldehyde dehydrogenase 1 as a ...... breast cancer: A meta-analysis

@nl

P1476

Aldehyde dehydrogenase 1 as a ...... breast cancer: A meta-analysis

@en

P2093

Bo Zhang

http://www.w3.org/2001/XMLSchema#string

Jian Jin

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Yan Fang Yang

http://www.w3.org/2001/XMLSchema#string

Yong Hong Liu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Global cancer statistics, 2012

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer

Markers of tumor-initiating cells predict chemoresistance in breast cancer.

CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer.

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.

Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer

Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.

Predictive markers of response to neoadjuvant chemotherapy in breast cancer.

P304

e12056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1097/MD.0000000000012056

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30142860

http://www.w3.org/2001/XMLSchema#string

P921

P932

6112948

http://www.w3.org/2001/XMLSchema#string